NCT05327972 - DEgenerative ROtator Cuff Disease and Botulinum TOXin | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 20, 2023

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2027

Conditions

Degenerative Rotator Cuff Disease

Interventions

DRUG

The investigational medicinal product is incobotulinumtoxinA (XEOMIN®).

Two milliliters of a mixture comprised of XEOMIN® 100 U and saline solution 0.9% will be once injected in the supra-spinatus muscle using ultrasonography guidance.

OTHER

PLACEBO

Two milliliters of a saline solution containing an inactive lyophilisate will be once injected in the supra-spinatus muscle using ultrasonography guidance.

Trial Locations (1)

75010

RECRUITING

Hôpital LARIBOISIERE, Paris